Smith, J
Ward, D
Michaelides, M
Moore, A T
Simpson, S
Article History
Received: 24 February 2015
Accepted: 25 May 2015
First Online: 26 June 2015
Competing interests
: Professor ATM is a Chairman of the data safety and management committee for the Oxford Biomedica and Sanofi gene therapy trials and is a consultant to Sanofi and Succampo. He has been an advisor to QLT and is involved in their current trial of oral retinoids for retinal dystrophies.